milmedВоенная медицинаMilitary Medicine2074-5044Белорусский государственный медицинский университетmilmed-395Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESКлассификация, диагностика и подходы к лечению ангиоотекаClassification, diagnosis, and approach to treatment for angioedemaМасловаЛ. В.MaslovaL. V.ГУ «Белорусская медицинская академия последипломного образования»Belarus2017191020260196100Copyright © Маслова Л.В., 20262026Маслова Л.В.Maslova L.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://milmed.ejournal.by/jour/article/view/395

Ангиоотеки являются не только медицинской, но и социальной, и экономической проблемой. Рост заболеваемости в некоторой степени связан с возрастающим приемом ингибиторов ангиотензинпревращающего фермента. Ангиоотек является жизнеугрожающим состоянием, поздняя диагностика, отсутствие препаратов для купирования острых приступов или краткосрочной, или долговременной профилактики, отсутствие знаний о болезни и способах ее контроля у пациента могут привести к летальному исходу. В обзоре приводится информация о классификации, диагностике, подходах к лечению и профилактике различных типов ангиоотека, основанная на результатах интернационального консенсуса по проблеме ангиоотека.

Аngioedema are not only medical but also social and economic problem. Increased incidence of some extent is associated with increased intake inhibitors of angiotensin-converting enzyme. Аngioedema is a life-threatening condition, late diagnosis, lack of drugs for the relief of acute attacks or short or long-term prevention, lack of knowledge about the disease and how to control the patient may lead to death. The review provides information on classification, diagnosis, approach to treatment and prevention for various types of angioedema, based on the results of the International consensus on the problem of angioedema.

ангиоотекс1-ингибиторбрадикининангиотензинпревращающий ферменткалликреинфактор XIIaangioedemaс1-inhibitorbradykininangiotensinconverting enzymekallikreinfactor XIIaReferencesBas, M. Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST-2 open-label study / M. Bas [et al.] // J. Allergy Clin. Immunol. — 2013. — Vol. 68, № 11. — P. 1452—1459.Bas, M. Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST-2 open-label study / M. Bas [et al.] // J. Allergy Clin. Immunol. — 2013. — Vol. 68, № 11. — P. 1452—1459.Boysen, H. B. Challenges of C1-Inhibitor Concentrate Self-Administration / H. B. Boysen [et al.] // J. Int Arch Allergy Immunol. — 2013. — 161(suppl 1). — P. 21—25.Boysen, H. B. Challenges of C1-Inhibitor Concentrate Self-Administration / H. B. Boysen [et al.] // J. Int Arch Allergy Immunol. — 2013. — 161(suppl 1). — P. 21—25.Caballero, T. Current Status of Implementation of Self-Administration Training in Various Regions of Europe, Canada and the USA in the Management of Hereditary Angioedema / T. Caballero [et al.] // J. Int Arch Allergy Immunol. — 2013. — 161(suppl 1). — P. 10—16.Caballero, T. Current Status of Implementation of Self-Administration Training in Various Regions of Europe, Canada and the USA in the Management of Hereditary Angioedema / T. Caballero [et al.] // J. Int Arch Allergy Immunol. — 2013. — 161(suppl 1). — P. 10—16.Charignon, D. Hereditary angioedema with F12 mutation: factors modifying the clinical phenotype / D. Charignon [et al.] // J. Allergy Clin. Immunol. — 2014. — Vol. 69, № 12. — P. 1659—1665.Charignon, D. Hereditary angioedema with F12 mutation: factors modifying the clinical phenotype / D. Charignon [et al.] // J. Allergy Clin. Immunol. — 2014. — Vol. 69, № 12. — P. 1659—1665.Cicardi, M. Review of Recent Guidelines and Consensus Statements on Hereditary Angioedema Therapy with Focus on Self-Administration / M. Cicardi [et al.] // J. Int Arch Allergy Immunol. — 2013. — 161(suppl 1). — P. 3—9.Cicardi, M. Review of Recent Guidelines and Consensus Statements on Hereditary Angioedema Therapy with Focus on Self-Administration / M. Cicardi [et al.] // J. Int Arch Allergy Immunol. — 2013. — 161(suppl 1). — P. 3—9.Cicardi, M. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group / M. Cicardi [et al.] // J. Allergy Clin. Immunol. — 2014. — Vol. 69, № 5. — P. 602—612.Cicardi, M. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group / M. Cicardi [et al.] // J. Allergy Clin. Immunol. — 2014. — Vol. 69, № 5. — P. 602—612.Ertoy Karagol, H. I. Angioedema without urticaria in childhood / H. I. Ertoy Karagol [et al.] // Pediatric Allergy and Immunology. — 2013. — Vol. 24, № 7. — P. 685—690.Ertoy Karagol, H. I. Angioedema without urticaria in childhood / H. I. Ertoy Karagol [et al.] // Pediatric Allergy and Immunology. — 2013. — Vol. 24, № 7. — P. 685—690.Giardino, F. Use of subcutaneous-C1 INH for acute therapy and prophylaxis of a child with HAE / F. Giardino [et al.] // Pediatric Allergy and Immunology. — 2015. — Vol. 26, № 3. — P. 296—297.Giardino, F. Use of subcutaneous-C1 INH for acute therapy and prophylaxis of a child with HAE / F. Giardino [et al.] // Pediatric Allergy and Immunology. — 2015. — Vol. 26, № 3. — P. 296—297.MacGinnite, A. J. Pediatric hereditary angioedema / A. J. MacGinnite // Pediatric Allergy and Immunology. — 2014. — Vol. 25. — P. 420—427.MacGinnite, A. J. Pediatric hereditary angioedema / A. J. MacGinnite // Pediatric Allergy and Immunology. — 2014. — Vol. 25. — P. 420—427.Maurer, M. Practical algorithm for diagnosing patients with recurrent wheals or angioedema / M. Maurer [et al.] // J. Allergy Clin. Immunol. — 2013. — Vol. 68, № 6. — P. 816 — 819.Maurer, M. Practical algorithm for diagnosing patients with recurrent wheals or angioedema / M. Maurer [et al.] // J. Allergy Clin. Immunol. — 2013. — Vol. 68, № 6. — P. 816 — 819.Schneider, L. C1-INH concentrate for treatment of acute hereditary angioedema: a pediatric cohort from the I. M. P. A. C. T. studies / L. Schneider [et al.] // Pediatric Allergy and Immunology. — 2013. — Vol. 24. — P. 54—60.Schneider, L. C1-INH concentrate for treatment of acute hereditary angioedema: a pediatric cohort from the I. M. P. A. C. T. studies / L. Schneider [et al.] // Pediatric Allergy and Immunology. — 2013. — Vol. 24. — P. 54—60.Symons, C. Practical Approach to Self-Administration of Intravenous C1-INH Concentrate: A Nursing Perspective / C. Symons [et al.] // J. Int Arch Allergy Immunol. — 2013. — 161 (suppl 1). — P. 17—20.Symons, C. Practical Approach to Self-Administration of Intravenous C1-INH Concentrate: A Nursing Perspective / C. Symons [et al.] // J. Int Arch Allergy Immunol. — 2013. — 161 (suppl 1). — P. 17—20.Timothy, J. C. Recent Advances in Hereditary Angioedema Self-Administration Treatment: Summary of an International Hereditary Angioedema Expert Meeting / J. C. Timothy [et al.] // J. Int Arch Allergy Immunol. — 2013. — 161 (suppl 1). — P. 1—2.Timothy, J. C. Recent Advances in Hereditary Angioedema Self-Administration Treatment: Summary of an International Hereditary Angioedema Expert Meeting / J. C. Timothy [et al.] // J. Int Arch Allergy Immunol. — 2013. — 161 (suppl 1). — P. 1—2.

The authors declare that there are no conflicts of interest present.